To the Editor,

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus causing Coronavirus Disease-19 (COVID-19), a global pandemic that has already changed our life from a medical point of view; the social and economic-financial consequences that the whole world will have to face and resolve will be enormous. It started in Wuhan in December 2019 and successively hit Italy, but it spread quickly in the whole Europe and in the rest of the world within a few weeks.

Most of the time patients present few and mild symptoms, such as fever, dry cough, dyspnea, myalgia, headache, anosmia and dysgeusia; in 3% of cases COVID-19 can have a serious evolution affecting the lungs, which can be fatal \[[@bb0005]\].

The main way of transmission of SARS-CoV-2 is through the respiratory system and the infection can spread to the lungs from the nose and the oropharynx.

In case of viral infections nasal mucosa usually appears swollen, edematous and is associated with rhinorrhea. Nasal scraping is a non-invasive method to take a sample of nasal mucosa; if the specimen is observed by an optical microscope \[[@bb0010],[@bb0015]\], characteristic cytopathic patterns can be evidenced, namely "ciliocytophthoria" (CCP) \[[@bb0020]\] and "multinucleation" \[[@bb0025]\], depending on the viruses involved.

CCP is the main sign of cell damage and is characterized by condensed nuclear chromatin, marginalization of nucleoli, inclusion bodies, presence of intranuclear halo and cytoplasmic vacuoles. The "hyperchromatic supranuclear stria" (SNS) ([Fig. 1](#f0005){ref-type="fig"}A, B) corresponds to the Golgi apparatus and is a marker for the anatomical and functional integrity of the ciliated cells, but it disappears during viral infections as a consequence of the cell damage \[[@bb0030],[@bb0035]\]. Influenza viruses and Adenoviruses are more aggressive than Rhinoviruses and Coronaviruses.Fig. 1A) Nasal cytology within normal limits. The arrow indicates the "hyperchromatic supranuclear stria", SNS (May-Grünwald-Giemsa, 2000× magnification); B) Normal ciliated cell (May-Grünwald-Giemsa, 1000× magnification); C, D) Nasal cytology in COVID-19 patient evidences binucleated cells, rarefaction of the cilia and absence of the hyperchromatic SNS (May-Grünwald-Giemsa, 1000× magnification); E, F) Bronchial cytology in COVID-19 patient reveals the absence of the hyperchromatic SNS (May-Grünwald-Giemsa, 1000× and 400× magnification).Abbreviations: Ci = ciliated cell; N = neutrophils.Fig. 1

In this letter the Authors describe the nasal and bronchial cytological aspects of a 63-year-old lady, who arrived at Melzo Hospital\'s emergency room (ER) in Milan, Italy, on March 25, 2020. The patient presented with the typical symptoms of COVID-19, such as rhinorrhea, fever, dyspnea and anosmia; the symptoms, which progressively worsened, have been already present for about ten days. The nasopharyngeal swab confirmed the suspected diagnosis of COVID-19. Additionally, the patient was affected by hypertension, obesity and ischemic heart disease.

Two days after hospital admission, her dyspnea worsened. The patient was transferred to the intensive care unit and orotracheal intubation was performed. Blood chemistry test and blood gas analysis results were abnormal. Chest X-ray showed diffuse areas of consolidation in the right lung and left lower lobe. Hearth size was within normal limits. Calcification of the aortic arch was evidenced.

After fourteen days of intubation, the Otolaryngologists were consulted to perform a tracheostomy and a 7-mm TracheoFlex® tube was inserted.

During bronchoscopy, bronchial brushing was executed. In the same session, nasal scraping was performed to obtain cells from the nasal mucosa.

The cytological specimens were stained using the May-Grünwald-Giemsa (MGG) stain. The samples were then observed under a light microscope at 1000× magnification.

The microscopic examination of the nasal ([Fig. 1](#f0005){ref-type="fig"}C, D) and bronchial mucosa ([Fig. 1](#f0005){ref-type="fig"}E, F) did not reveal important cytological and pathological alterations. The typical cytopathic changes that are usually found in viral respiratory infections, such as CCP and multinucleation, were not detected, except for a partial rarefaction of the cilia, the presence of some binucleated cells and the reduction/disappearance of the hyperchromatic SNS. The observation of the bronchial sample also revealed an abnormally high number of neutrophils.

Therefore, the cytopathic alterations were of little significance. A possible explanation could be the irrelevant naso-bronchial symptoms that usually affect COVID-19 patients, especially asymptomatic or mildly symptomatic. Conversely, something completely different happens in the lung parenchyma. In fact, it is widely accepted that an exaggerated inflammatory response to SARS-CoV-2 could contribute to lung disease. As a consequence, the intense inflammatory response triggers thrombotic phenomena in the blood vessels, leading to a condition of disseminated intravascular coagulation (DIC). In the most serious cases, these alterations can involve also the kidneys, the liver and the brain \[[@bb0040]\]. Coagulopathy in COVID-19 is correlated with elevated D-dimer levels and high mortality rates. The use of anticoagulant therapy with low molecular weight heparin that has been proposed is consistent with this observation \[[@bb0045]\].

In conclusion, we would probably expect greater microscopic alterations in the pulmonary alveoli, but for this purpose we recommend to perform a histological analysis, which remains the gold standard for tissue assessment.
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